|
|
| Countries covered: United States Research Overview This Frost & Sullivan research service entitled U.S. Transdermal Drug Delivery Market provides pipeline analysis, forecasts, and technology overviews. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, pain management, vaccines, and sexual dysfunction. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
The following technologies are covered in this research:
The transdermal drug delivery market is entering a new phase in which pain management is no longer the growth driver for the industry. Diseases and disorders of the central nervous system are providing excellent opportunities for transdermal drug delivery with two new products launched in early 2006. The use of transdermal drug delivery in depression and attention deficit hyperactivity disorder are poised to provide substantial growth for the industry and counteract the loss of patent protection of the largest transdermal drug, Duragesic. A multitude of new products are in development covering all three categories of pain management opioid, non-steroidal anti-inflamatory drugs, and topical pain relief. These new products are expected to provide new therapy options for patients as well as growth of the market. The transdermal drug delivery market was solely based on passive patch technology that relied on simple diffusion across the skin. With the approval of Synera and IONSYS, active patches utilizing an external energy source are now on the market. Active patches offer a wider array of capabilities allowing for delivery of compounds over 500 daltons and those with challenging physical properties, allowing many companies to develop active patches to deliver pain management drugs, proteins, and vaccines to better control delivery and add value to patients disease management. Passive patch technology is still developing as well, creating smaller patches with better adhesion. These patches continue to control the hormone market and CNS segments with CNS providing the most growth due to entry into new disease indications. |
More United States Allergy/Immunology Reports
Cough, Cold and Allergy (Hay Fever) Remedies in the US by
Euromonitor International
In 2011, Chattem Inc’s Allegra brand of antihistamine/allergy remedies (systemic) switched from Rx-to-OTC, representing one of the largest switches in the segment’s history. First stocked ...
Cough & Cold Medicine Manufacturing OTC in the US - Industry Market Research Report by
IBISWorld
Get well: Seasonal colds will facilitate growth, but prescription drugs will limit demand Cough & Cold Medicine Manufacturing OTC Get well The necessary nature of cough and cold ...
Cough, Cold and Allergy (hay Fever) Remedies - USA by
Euromonitor International
Two very important active ingredients in cough and cold products were the subject of heated regulatory discussion in 2010. Pseudoephedrine (PSE), a powerful decongestant, attracted ...
Gluten-Free Foods and Beverages in the U.S., 3rd Edition by
Packaged Facts
"Are you gluten-free?" The term describes more than the sector of the food and beverage industry that has morphed from specialty niche to mainstream ...
Allergy Drugs by
Global Industry Analysts
This report analyzes the US Market for Allergy Drugs in US$ Million by the following types - Prescription Antihistamines, Prescription Corticosteroids, and OTC Allergy Drugs. ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
- Diseases & Conditions
- Pain
- Drug Delivery
- Transdermal & Implantable
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals
- Vaccines
- Drug Delivery
- Therapeutic Area
- Allergy/Immunology
